Tech Company M&A Transactions
Celladon Acquisition
Based in San Diego, Celladon was acquired by Eiger BioPharmaceuticals. What Eiger BioPharmaceuticals paid for Celladon was not announced.
Transaction Overview
Company Name
Acquired By
Announced On
11/23/2015
Transaction Type
M&A
Amount
Unknown
M&A Terms
The proposed merger will create a clinical-stage company with a diversified development portfolio of product candidates addressing novel targets for four distinct orphan diseases: Hepatitis Delta Virus, bariatric surgery-induced hyperinsulinemic hypoglycemia, pulmonary arterial hypertension, and lymphedema.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12760 High Bluff Dr. 240
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Celladon Corporation is an exciting new biotechnology company focused on developing treatments for cardiovascular diseases through the application of scientific discoveries in molecular cardiology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Krisztina Zsebo
VP - Finance
Rebecque Laba
VP - General Counsel
Elizabeth Reed
VP - Operations
Jeffrey Rudy
Browse more venture capital transactions:
Prev: 11/23/2015: iMapData venture capital transaction
Next: 11/23/2015: Smartly venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs